Nearly all surveyed drug sellers (i.e. pharmacists) in the capital city of Seoul indicated a decrease, whether small or large, in outpatient prescriptions following the COVID-19 outbreak in South Korea in early 2020. This trend matches that of most other regions in Korea. Only a small share of four percent of the pharmacists in Seoul said there had been no change or even increases in prescriptions. This decrease is attributed to fewer hospital visits in the midst of the COVID-19 crisis.
Changes in hospital outpatient prescriptions since COVID-19 outbreak in Seoul in South Korea in 2020
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Coronavirus: the pharma and medtech response
Pharma - before the pandemic
6
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Top global pharmaceutical companies based on pharma revenue 2022
- Premium Statistic Size of the global vaccine market by region 2014-2024
- Premium Statistic Leading pharmaceutical companies by global vaccine revenue 2021
- Basic Statistic Global anti-viral market size 2019 and 2027 forecast
- Premium Statistic Leading pharmaceutical companies by global anti-viral revenue 2017 and 2024
Treatments and vaccines
8
- Basic Statistic Biotechs: duration of COVID-19 response compared to previous health threats 2003-2019
- Premium Statistic Number of registered COVID-19 studies worldwide Apr 2020 - Dec 2022, by region
- Basic Statistic Number of COVID-19 drugs in development worldwide by phase June 2022
- Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
- Basic Statistic Number of COVID-19 treatment vaccine trials worldwide by phase June 2022
- Basic Statistic Number of COVID-19 treatment vaccine trials worldwide by type June 2022
- Premium Statistic Select COVID-19 vaccine pricing and funding as of August 2020
- Basic Statistic Gilead Science's remdesivir manufacturing projections 2020
Focus: BioNTech and Moderna
7
- Basic Statistic COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020
- Basic Statistic Revenue of BioNTech 2017-2023
- Basic Statistic Operating income of BioNTech 2017-2023
- Basic Statistic Total assets of BioNTech 2017-2023
- Basic Statistic Moderna's revenue 2016-2023
- Basic Statistic R&D expenses of Moderna 2016-2023
- Basic Statistic R&D expenses of Moderna by type 2023
Opinions on COVID-19 vaccines
6
- Basic Statistic U.S. adults who would get a coronavirus vaccine, Jan. 2020 to Jan. 2021
- Basic Statistic U.S. adults who would hypothetically get a coronavirus vaccine as of 2020, by gender
- Basic Statistic U.S. adults who would hypothetically get a coronavirus vaccine October 2020, by age
- Basic Statistic Share of Canadians who would get vaccinated for COVID Jul. 2020 - Mar. 2021
- Premium Statistic Willingness to wait before getting COVID-19 vaccine once available in Italy 2020
- Basic Statistic Brazil: intention to get immunized against COVID-19 2021
Business impact
4
- Basic Statistic Market capitalization change in key COVID-19 firms until end-May 2020
- Basic Statistic Top challenges for pharmaceutical companies during COVID-19 2020
- Basic Statistic Launch disruption on global pharmaceutical market due to coronavirus 2020-2025
- Premium Statistic Covid-19 impact: global pharma specialty excipient demand CAGR 2019-2024
Medtech - before the pandemic
5
- Premium Statistic Total medtech revenue worldwide 2011-2024
- Premium Statistic In-vitro diagnostics market revenue worldwide 2016-2028
- Premium Statistic Global in vitro diagnostics market share by top medtech companies 2017 and 2024
- Basic Statistic Global ventilator market size 2018-2026
- Premium Statistic Global ventilator market size by type 2018-2026
Ventilators and testing
7
- Basic Statistic Number of COVID-19-related EUAs for ventilators developed by company May 2020
- Basic Statistic Respiratory devices with potential being modified to ventilators by company 2020
- Basic Statistic Weekly ventilator production change in U.S. due to COVID-19 until April 2020
- Basic Statistic Cumulative EUAs granted to COVID-19 tests March-November 2020
- Basic Statistic Accuracy figures for selected COVID-19 antibody tests sold in the US 2020
- Basic Statistic Number of COVID-19 tests carried out daily in U.S. March-November2020
- Basic Statistic Rate change of COVID-19 testing in select countries April-November 2020
Further related statistics
10
- Key figures on established biotech centers worldwide 2012-2016
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- MorphoSys' research & development expenditure 2006-2023
- MorphoSys' revenue 2006-2023
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
Further Content: You might find this interesting as well
Statistics
- Key figures on established biotech centers worldwide 2012-2016
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- MorphoSys' research & development expenditure 2006-2023
- MorphoSys' revenue 2006-2023
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
IQVIA. (March 31, 2020). Changes in hospital outpatient prescriptions since COVID-19 outbreak in Seoul in South Korea in 2020 [Graph]. In Statista. Retrieved June 17, 2024, from https://www.statista.com/statistics/1120091/south-korea-changes-in-outpatient-prescriptions-during-covid-19-seoul/
IQVIA. "Changes in hospital outpatient prescriptions since COVID-19 outbreak in Seoul in South Korea in 2020." Chart. March 31, 2020. Statista. Accessed June 17, 2024. https://www.statista.com/statistics/1120091/south-korea-changes-in-outpatient-prescriptions-during-covid-19-seoul/
IQVIA. (2020). Changes in hospital outpatient prescriptions since COVID-19 outbreak in Seoul in South Korea in 2020. Statista. Statista Inc.. Accessed: June 17, 2024. https://www.statista.com/statistics/1120091/south-korea-changes-in-outpatient-prescriptions-during-covid-19-seoul/
IQVIA. "Changes in Hospital Outpatient Prescriptions since Covid-19 Outbreak in Seoul in South Korea in 2020." Statista, Statista Inc., 31 Mar 2020, https://www.statista.com/statistics/1120091/south-korea-changes-in-outpatient-prescriptions-during-covid-19-seoul/
IQVIA, Changes in hospital outpatient prescriptions since COVID-19 outbreak in Seoul in South Korea in 2020 Statista, https://www.statista.com/statistics/1120091/south-korea-changes-in-outpatient-prescriptions-during-covid-19-seoul/ (last visited June 17, 2024)
Changes in hospital outpatient prescriptions since COVID-19 outbreak in Seoul in South Korea in 2020 [Graph], IQVIA, March 31, 2020. [Online]. Available: https://www.statista.com/statistics/1120091/south-korea-changes-in-outpatient-prescriptions-during-covid-19-seoul/